Aspirin and angiotensin-converting enzyme inhibitors among elderly survivors of hospitalization for an acute myocardial infarction

Archives of Internal Medicine

Volumn 161, Issue 4, 2001, Pages 538-544

  Krumholz, Harlan M ^a,b,c   Chen, Ya Ting ^a,d   Wang, Yongfei ^a   Radford, Martha J ^a,b,c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE NEW HAVEN HOSPITAL   (United States)

^c QUALIDIGM   (United States)

^d MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ACUTE HEART INFARCTION; AGED; ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG CHOICE; DRUG CROSS REACTIVITY; DRUG MECHANISM; ELDERLY CARE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PRIORITY JOURNAL; SURVIVAL TIME;

EID: 0035952232     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.161.4.538     Document Type: Article

References (20)

1. ACC/AHA guidelines for the management of patients with acute myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
2. Adjunctive drug therapy of acute myocardial infarction - Evidence from the clinical trials
3. Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure
4. Effect of angiotensin-converting enzyme inhibitors on endothelium-dependent peripheral vasodilation in patients with chronic heart failure
5. Acute hemodynamic interaction of aspirin and ticlopidine with enalapril: Results of a double-blind, randomized comparative trial
6. Effects of acetylsalicylic acid on renal function in patients with chronic heart failure
7. Angiotensin-converting enzyme inhibitors and renal function in heart failure
8. Interaction between enalapril and aspirin on mortality after acute myocardial infarction: Subgroup analysis of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)
9. Antiplatelet agents and survival: A cohort analysis from the Studies of Left Ventricular Dysfunction (SOLVD) trial
10. Endothelium-dependent relaxation by angiotensin-converting enzyme inhibitors in canine femoral arteries
11. Improving the quality of care for Medicare patients with acute myocardial infarction: Results from the Cooperative Cardiovascular Project
12. Studying outcomes and hospital utilization in the elderly: The advantages of a merged data base for Medicare and Veterans Affairs hospitals
13. Antiplatelet Trialists' Collaboration Collaborative overview of randomised trials of antiplatelet therapy - I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
14. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: Resuits of the Survival and Ventricular Enlargement Trial (SAVE)
15. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure
16. Effect of ACE inhibitor trandolapril on life expectancy of patients with reduced leff-ventricular function after acute myocardial infarction: Trandolapril Cardiac Evaluation
17. Developing improved observational methods for evaluating therapeutic effectiveness
18. Aspirin for secondary prevention after acute myocardial infarction in the elderly: Prescribed use and outcomes
19. Effects of an angiotensin-convertingenzyme inhibitor, ramipril, on cardiovascular events in highrisk patients